Heart Valves Market Forecast
The Heart Valves Market is on a trajectory of substantial growth, with market forecasts predicting a significant increase in its size and scope. The market, estimated at $13.35 billion in 2025, is projected to reach an impressive $23.32 billion by 2030, with a strong CAGR of 11.8%. This positive forecast is largely attributed to the continued and expanding use of transcatheter heart valves, particularly TAVR, which is moving beyond high-risk patients to include intermediate and low-risk populations. The forecast also anticipates a surge in the development and adoption of transcatheter solutions for mitral and tricuspid valve diseases, which currently have a high unmet need. The market's future is further bolstered by the global aging population, as older individuals are more susceptible to valvular heart diseases. The forecast for heart valves also accounts for the increasing investment in research and development, which is leading to the creation of more durable and biocompatible valves, as well as more precise and user-friendly delivery systems.
The forecast for the heart valves market also highlights a shift in regional dynamics. While North America is expected to maintain its leadership position, the Asia-Pacific region is forecasted to exhibit the highest growth rate, driven by a combination of improving healthcare infrastructure, a large patient base, and rising healthcare expenditures. The forecast anticipates a continued dominance of replacement procedures over repair procedures, although innovations in repair technologies, such as transcatheter mitral valve repair (TMVr), are expected to gain traction. The market forecast is also influenced by the growing role of hospitals and ambulatory surgical centers as key end-users. The overall forecast for the heart valves market is extremely optimistic, reflecting a dynamic industry where technological innovation and demographic shifts are creating significant opportunities for growth and expansion.